News Sentiment

CYRX sentiment intelligence

Cryoport Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed

Weighted score 58 Balanced news tone 53 relevant articles

Exchange NASDAQ United States

Sector Industrials Market context

Industry Integrated Freight & Logistics Read-through group

Latest close 16.17 Week of 10 Jul 2026

Weighted tone 58/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

77/100 classification confidence.

Company focus 53

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+4.4% over one week, +10.6% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

(CYRX) as a Liquidity Pulse for Institutional Tactics

Market Reaction

Price moving ahead of tone

67/100 confidence

Primary event Market update 77/100 classification

One-week reaction 4.4% Price confirming higher

Trend fit Trend active 10.6% over four weeks

Fair value 55.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance

Positive 18

Neutral 33

Negative 2

Relevance

Why the article matched

Direct first

Direct company coverage 53

Industry context 0

Sector context 0

Sources

Coverage mix

Publishers

Stock Titan 9

TradingKey 8

TradingView 6

MarketBeat 5

Market source 3

Stock Traders Daily 2

Quartr 2

PR Newswire 2

Event Lens

What the news is about

Classified themes

Market update 25

Earnings 17

Analyst action 4

Deals and strategy 3

Balance sheet 1

Macro sensitivity 1

Capital return 1

Guidance 1

Sentiment Trail

Score over time

50 baseline

Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 53

Stock Traders Daily Direct company coverage

(CYRX) as a Liquidity Pulse for Institutional Tactics

This article analyzes Cryoport Inc. (NASDAQ: CYRX), indicating a strong sentiment across all horizons and significant upside potential due to the absence of resistance levels above the current price. It presents three AI-generated institutional trading strategies: a Position Trad

Tone: Positive 72/100
Event: Balance sheet
Published: 14 Jul 2026 03:40
Source: Stock Traders Daily

MarketBeat Direct company coverage

SG Americas Securities LLC Cuts Stock Holdings in CryoPort, Inc. $CYRX

SG Americas Securities LLC significantly reduced its stake in CryoPort (NASDAQ:CYRX) by 87.2% in the first quarter, now holding 15,252 shares worth $126,000. Despite this, several analysts maintain a "Moderate Buy" rating for CryoPort with an average price target of $15.11, and t

Tone: Negative 39/100
Event: Analyst action
Published: 13 Jul 2026 09:10
Source: MarketBeat

Ad-hoc-news.de Direct company coverage

CYRX stock stays supported by cold chain demand and biotech logistics growth

Cryoport Inc. (CYRX) specializes in temperature-controlled logistics for advanced biopharmaceuticals and reproductive medicine, including cell and gene therapies. The company's stock is supported by the expanding demand for reliable cold chain solutions in the life sciences secto

Tone: Positive 74/100
Event: Macro sensitivity
Published: 09 Jul 2026 17:18
Source: Ad-hoc-news.de

MarketBeat Direct company coverage

CryoPort (NASDAQ:CYRX) Stock Crosses Above Two Hundred Day Moving Average - Here's Why

CryoPort (NASDAQ:CYRX) stock crossed above its 200-day moving average, reaching $15.28, a 1.3% gain. Analysts generally hold a "Moderate Buy" rating with a consensus target of $15.11, though insider selling has been observed with over 227,000 shares sold recently. The company, a

Tone: Positive 64/100
Event: Analyst action
Published: 09 Jul 2026 08:12
Source: MarketBeat

AD HOC NEWS Direct company coverage

Cryoport Inc outlines its logistics role for cell and gene therapies

Cryoport Inc specializes in providing temperature-controlled logistics for sensitive biological materials, particularly for cell and gene therapies. The company's services include cryogenic shipping systems, specialized packaging, and temperature monitoring, which are crucial for

Tone: Positive 81/100
Event: Market update
Published: 07 Jul 2026 12:14
Source: AD HOC NEWS

Quartr Direct company coverage

Cryoport (CYRX) Investor presentation Summary

This article summarizes Cryoport's investor presentation on June 30, 2026, highlighting its strategic positioning as a critical infrastructure provider for the cell and gene therapy industry. It covers the company's financial performance, including Q3 2024 revenue of $56.7M and f

Tone: Positive 64/100
Event: Earnings
Published: 30 Jun 2026 03:11
Source: Quartr

TradingView Direct company coverage

CryoPort, Inc. Actuals & Estimates (NASDAQ:CYRX)

This article provides an overview of CryoPort, Inc. (NASDAQ: CYRX) financials, analyst estimates, and stock performance. It details the company's current stock price, market capitalization, earnings, and revenue, alongside analyst price targets and historical highs and lows. The

Tone: Positive 63/100
Event: Earnings
Published: 27 Jun 2026 10:09
Source: TradingView

TradingView Direct company coverage

Enterprise value to revenue forward of CryoPort, Inc. – NASDAQ:CYRX

This article focuses on the enterprise value to revenue forward metric for CryoPort, Inc. (NASDAQ:CYRX). It presents key financial data and market information related to the company's valuation. The content appears to be a financial snapshot provided by TradingView, detailing var

Tone: Neutral 50/100
Event: Earnings
Published: 27 Jun 2026 09:40
Source: TradingView

MarketBeat Direct company coverage

CryoPort, Inc. $CYRX Shares Bought by Penbrook Management LLC

Penbrook Management LLC significantly increased its stake in CryoPort, Inc. (NASDAQ:CYRX) by 251.6% in the first quarter, adding 132,940 shares. Other institutional investors like AQR Capital Management LLC and Creative Planning also adjusted their positions, with 92.90% of the s

Tone: Neutral 50/100
Event: Earnings
Published: 27 Jun 2026 09:40
Source: MarketBeat

TradingView Direct company coverage

Price to book forward of CryoPort, Inc. – NASDAQ:CYRX

This article provides a financial data point for CryoPort, Inc. (NASDAQ: CYRX), specifically its "Price to book forward" value without stating the actual value. It indicates that the data was "Made by humans" and lists various sources for market and reference data, including ICE

Tone: Neutral 50/100
Event: Market update
Published: 27 Jun 2026 00:40
Source: TradingView

TradingView Direct company coverage

Price to earnings forward of CryoPort, Inc. – MUN:CKX

This page provides financial information for CryoPort, Inc. (CKX) on the Munich Stock Exchange, specifically focusing on its forward price-to-earnings ratio. The content appears to be a stub or a section within a larger financial data platform.

Tone: Neutral 50/100
Event: Earnings
Published: 26 Jun 2026 14:40
Source: TradingView

Moomoo Direct company coverage

Cryoport's IntegriCell Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs

Cryoport, a leading provider of temperature-controlled supply chain solutions for the life sciences, announced that Verismo Therapeutics has selected its IntegriCell cryopreservation services. This partnership aims to support Verismo's clinical KIR-CAR T cell therapy programs, en

Tone: Positive 72/100
Event: Deals and strategy
Published: 26 Jun 2026 09:40
Source: Moomoo

The Globe and Mail Direct company coverage

Analysts Offer Insights on Industrial Goods Companies: CryoPort (CYRX) and United Rentals (URI)

Tone: Neutral 50/100
Event: Market update
Published: 26 Jun 2026 07:00
Source: The Globe and Mail

TradingView Direct company coverage

CYRX Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for CryoPort, Inc. (CYRX) stock for 2027, based on analyst opinions. It details current stock performance, historical highs and lows, financial metrics like market capitalization, earnings, revenue, and EBITDA, and does not sugges

Tone: Positive 77/100
Event: Earnings
Published: 26 Jun 2026 05:12
Source: TradingView

TradingView Direct company coverage

Enterprise value to EBITDA forward of CryoPort, Inc. – GETTEX:CKX

This article focuses on the enterprise value to EBITDA forward for CryoPort, Inc. (GETTEX:CKX). It appears to be a stub or data-point article from TradingView, providing financial metrics for the company within the Air Freight/Couriers sector. The content includes a brief mention

Tone: Neutral 50/100
Event: Market update
Published: 26 Jun 2026 05:12
Source: TradingView

marketscreener.com Direct company coverage

CryoPort to Provide IntegriCell Cryopreservation Services for Verismo's Development Programs

Cryoport Systems, a subsidiary of Cryoport, Inc., has been selected by Verismo Therapeutics to provide IntegriCell Cryopreservation services. These services will support Verismo's clinical Kir-Car T cell therapy programs. This announcement highlights Cryoport's role in supplying

Tone: Positive 71/100
Event: Market update
Published: 25 Jun 2026 13:10
Source: marketscreener.com

PR Newswire Direct company coverage

Cryoport's IntegriCell® Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs

Cryoport Systems' IntegriCell cryopreservation services have been selected by Verismo Therapeutics to support its clinical KIR-CAR T cell therapy programs, SynKIR™-110 and SynKIR™-310. This partnership aims to standardize and scale Verismo's cryopreservation processes, ensuring c

Tone: Positive 74/100
Event: Deals and strategy
Published: 25 Jun 2026 12:10
Source: PR Newswire

Investing.com Australia Direct company coverage

Cryoport’s IntegriCell selected for Verismo therapy programs By Investing.com

Cryoport, Inc. announced that its IntegriCell cryopreservation services have been chosen by Verismo Therapeutics to support two clinical-stage CAR T cell therapy programs, SynKIR-110 and SynKIR-310, which are both in Phase 1 trials. This partnership will include process developme

Tone: Positive 71/100
Event: Deals and strategy
Published: 25 Jun 2026 12:10
Source: Investing.com Australia

Stock Titan Direct company coverage

Cryoport lands Verismo for clinical cell therapy cryopreservation

Tone: Neutral 50/100
Event: Market update
Published: 25 Jun 2026 07:00
Source: Stock Titan

Stock Titan Direct company coverage

[15-12G] Cryoport, Inc. SEC Filing

Cryoport, Inc. filed Form 15-12G with the SEC to terminate or suspend its duty to file reports under Sections 13 and 15(d) of the Securities Exchange Act of 1934. The filing indicates the termination relies on Rule 12g-4(a)(1) and states that the warrants to purchase common stock

Tone: Neutral 50/100
Event: Market update
Published: 22 Jun 2026 21:10
Source: Stock Titan

Stock Traders Daily Direct company coverage

(CYRX) Movement as an Input in Quant Signal Sets

This article from Stock Traders Daily discusses Cryoport Inc. (NASDAQ: CYRX) and its movement within quantitative signal sets. It highlights positive near-term sentiment while noting a weak mid-term bias within a long-term strength context. The analysis provides AI-generated sign

Tone: Positive 73/100
Event: Market update
Published: 22 Jun 2026 01:24
Source: Stock Traders Daily

Quartr Direct company coverage

Cryoport (CYRX) Proxy Filing Summary

This article summarizes Cryoport's (CYRX) proxy filing, detailing the upcoming annual meeting scheduled for June 6, 2025. Shareholders will vote on the election of six directors, the ratification of Deloitte & Touche LLP as independent auditor, advisory votes on executive compens

Tone: Positive 67/100
Event: Market update
Published: 21 Jun 2026 09:39
Source: Quartr